Racotumomab: an anti-idiotype vaccine related to N-glycolyl-containing gangliosides - preclinical and clinical data - Wikidata - wikimedia - TriplyDB

Racotumomab: an anti-idiotype vaccine related to N-glycolyl-containing gangliosides - preclinical and clinical data

Racotumomab: an anti-idiotype vaccine related to N-glycolyl-containing gangliosides - preclinical and clinical data

http://www.wikidata.org/entity/Q30575331

about

Glycosylation of glycolipids in cancer: basis for development of novel therapeutic approaches Natural Antibodies as Rheostats for Susceptibility to Chronic Diseases in the Aged Dysregulated Expression of Glycolipids in Tumor Cells: From Negative Modulator of Anti-tumor Immunity to Promising Targets for Developing Therapeutic Agents Antibodies to watch in 2015 Current state of immunotherapy for non-small cell lung cancer.Challenges and opportunities for cancer vaccines in the current NSCLC clinical scenario.Immunotherapy prospects in the treatment of lung cancer and mesothelioma.Anti-bevacizumab idiotype antibody vaccination is effective in inducing vascular endothelial growth factor-binding response, impairing tumor outgrowth.Anti-idiotype antibodies in cancer treatment.

P2860

Q21129299-722CAD4C-2C72-4DCF-89F4-060E56DFBA08 Q26752508-F4DE36B6-4988-4EA2-958C-BC11CEF0A0F1 Q26771367-BB994D04-A43A-46C6-A4E7-D01280D8A68D Q28253501-B6C64589-9BB7-4568-9B79-A9D4BA34084C Q33645595-6E59A8CF-DE1C-472E-9C0A-5BB3AEA0C921 Q38143201-1C38D0BF-D249-4139-92D8-26892B5048C8 Q38390104-AC9D7F28-1220-44E9-B743-B4C34E895D42 Q38778205-E7C0A744-DA7F-46D6-ACC9-61F2903DBF25 Q42219478-98AECCA1-3436-4FE6-AEDA-6F591847D9F2

P2860

Racotumomab: an anti-idiotype vaccine related to N-glycolyl-containing gangliosides - preclinical and clinical data

http://www.wikidata.org/entity/Q30575331

description

2012 nî lūn-bûn

@nan

2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Racotumomab: an anti-idiotype ...... preclinical and clinical data

@ast

Racotumomab: an anti-idiotype ...... preclinical and clinical data

@en

type

label

Racotumomab: an anti-idiotype ...... preclinical and clinical data

@ast

Racotumomab: an anti-idiotype ...... preclinical and clinical data

@en

prefLabel

Racotumomab: an anti-idiotype ...... preclinical and clinical data

@ast

Racotumomab: an anti-idiotype ...... preclinical and clinical data

@en

P1433

Q30575331-E55FE393-31AD-4027-B44B-B7B1795AE546

P1476

Q30575331-ED9BEF4B-8453-4F09-AB8C-D73FEA46D3A2

P2093

Q30575331-053B5290-8B47-4586-BD9A-985EE74FBE30

Q30575331-163BD75C-695D-4300-8290-BE7C9C74C3B6

Q30575331-18984DB7-96CF-4729-BC7A-601201EF7FE6

Q30575331-1A6D38D4-B409-49EF-A89C-54FE3C8FCD99

Q30575331-8960E4EB-B9C8-4F1E-8EE6-F4AEF1462BDC

Q30575331-A51C1274-108A-4564-A637-C96A6003F770

Q30575331-D35B2D83-96CB-482D-967E-68941260D3F3

Q30575331-DD934872-7637-468F-B6F2-A6EEADD3F851

P2860

Q30575331-064D74D3-9E5A-4550-8883-3A335FC5C721

Q30575331-066025F7-7C00-4020-8876-F2EBD619A4C2

Q30575331-092124D7-5004-4788-8D3D-2EED373D9FF0

Q30575331-14266E7A-09EA-4172-A299-CE5CA6D5709A

Q30575331-1635D6E8-1D7A-451B-88D3-DC1C3DFF02BA

Q30575331-1F8B5B60-1140-44BA-AD88-8967448F0434

Q30575331-1FC6419C-2AE4-4E6D-993C-8049277DCB60

Q30575331-26091647-C278-4F8F-8139-9E18F341F2BF

Q30575331-2B7F2BE7-0D06-4FB9-8A9B-1573141F2C91

Q30575331-34253004-7FEB-407F-8A9B-2411AC3251FA

P304

Q30575331-5E37067C-AB1C-4DFC-B7C3-8D1134BF0EB0

P31

Q30575331-30E70C16-6017-4319-881E-B89D81B03B56

P356

Q30575331-BF89B444-F592-4C0B-996D-D6EF886C0B7A

P478

Q30575331-A518B2BD-4490-40BB-8B96-8F970AA22759

P577

Q30575331-1F793E50-AE4C-46C9-A20C-56E8418F526B

P5875

Q30575331-0D336727-4E73-45F6-B156-86B238D4CC00

P698

Q30575331-756D4C74-CBA5-497B-831F-369CD29DFCF4

P932

Q30575331-38AC63DC-9B26-41ED-BE15-56BF1E89AACF

P356

FONC.2012.00150

P1433

Frontiers in Oncology

P1476

Racotumomab: an anti-idiotype ...... preclinical and clinical data

@en

P2093

Amparo Macías

http://www.w3.org/2001/XMLSchema#string

Ana M Hernández

http://www.w3.org/2001/XMLSchema#string

Ana M Vázquez

http://www.w3.org/2001/XMLSchema#string

Daniel E Gómez

http://www.w3.org/2001/XMLSchema#string

Daniel F Alonso

http://www.w3.org/2001/XMLSchema#string

Enrique Montero

http://www.w3.org/2001/XMLSchema#string

Mariano R Gabri

http://www.w3.org/2001/XMLSchema#string

Roberto E Gómez

http://www.w3.org/2001/XMLSchema#string

P2860

Sequencing the chimpanzee genome: insights into human evolution and disease

A mutation in human CMP-sialic acid hydroxylase occurred after the Homo-Pan divergence

Alu-mediated inactivation of the human CMP- N-acetylneuraminic acid hydroxylase gene

Therapeutic vaccination with epidermal growth factor (EGF) in advanced lung cancer: analysis of pooled data from three clinical trials.

Tissue micro array analysis of ganglioside N-glycolyl GM3 expression and signal transducer and activator of transcription (STAT)-3 activation in relation to dendritic cell infiltration and microvessel density in non-small cell lung cancer

Anti-idiotype vaccine against cancer.

Physicochemical and biological characterization of 1E10 anti-idiotype vaccine.

Tolerance to self gangliosides is the major factor restricting the antibody response to lipopolysaccharide core oligosaccharides in Campylobacter jejuni strains associated with Guillain-Barré syndrome.

B cells regulate autoimmunity by provision of IL-10.

The anti-idiotype vaccines for immunotherapy.

P304

150

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FONC.2012.00150

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2012-10-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232740026

http://www.w3.org/2001/XMLSchema#string

P698

23110257

http://www.w3.org/2001/XMLSchema#string

P932

3478665

http://www.w3.org/2001/XMLSchema#string